Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial. Ciardiello D, Martini G, Bielo LB, Pietrantonio F, et al. Ann Oncol 2025 Dec 22:S0923-7534(25)06334-3. doi: 10.1016/j.annonc.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Ciardiello D, Martini G, Bielo LB, Pietrantonio F, et al. Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial. Ann Oncol 2025 Dec 22:S0923-7534(25)06334-3. doi: 10.1016/j.annonc.2025.
PMID: 41443411